RELAXO FOOTWEARS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 832.2 INR | +0.82% |
|
+0.68% | -7.89% |
| 05-10 | Transcript : Relaxo Footwears Limited, Q4 2024 Earnings Call, May 10, 2024 | |
| 05-10 | Relaxo Footwears' Net Profit Slips in Fiscal Q4 | MT |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company is in a robust financial situation considering its net cash and margin position.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 101.84 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Footwear
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -7.89% | 2.47B | - | ||
| +34.60% | 23.09B | B+ | ||
| +32.50% | 11.25B | C+ | ||
| +9.70% | 10.43B | C | ||
| -2.32% | 8.94B | - | ||
| +54.61% | 8.77B | B- | ||
| -1.88% | 8.13B | A- | ||
| +23.14% | 3.47B | A- | ||
| +79.40% | 3.17B | B- | ||
| -17.30% | 2.1B | B |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
- Stock Market
- Equities
- RELAXO Stock
- RELAXO Stock
- Ratings Relaxo Footwears Limited